Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Future Medicinal Chemistry
|
June 17, 2021
Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion?
Maria João Matos
Molecules (Basel, Switzerland)
|
October 23, 2021
Coumarin and Its Derivatives-Editorial
Maria João Matos
Future Medicinal Chemistry
|
May 6, 2022
Treating neurodegenerative diseases with multitarget drugs: an interview with Maria João Matos
Maria João Matos
ACS Medicinal Chemistry Letters
|
June 16, 2022
Medicinal Chemistry in Portugal and Spain: A Strong Iberian Alliance
Maria João Matos, Maria-Jesus Blanco
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2023
Oxidation-labile linkers for controlled drug delivery
Aitor Carneiro, Lourdes Santana, Maria João Matos
Marine Drugs
|
January 20, 2023
Recent Advances in Biologically Active Coumarins from Marine Sources: Synthesis and Evaluation
Laura Fernández-Peña, Maria João Matos, Enol López
Molecules (Basel, Switzerland)
|
January 22, 2021
Trending Topics on Coumarin and Its Derivatives in 2020
Aitor Carneiro, Maria João Matos, Eugenio Uriarte, et al.
Future Medicinal Chemistry
|
February 21, 2023
Propargylamine: an important moiety in drug discovery
Aitor Carneiro, Eugenio Uriarte, Fernanda Borges, et al.
Expert Opinion on Drug Discovery
|
March 16, 2026
The futility of the familiar: rethinking strategies for the development of small molecules for neurodegenerative disorders
Manuel Novas, Maria João Matos, Christina Li Lin Chai
Expert Opinion on Therapeutic Patents
|
January 20, 2015
Potential pharmacological uses of chalcones: a patent review (from June 2011 - 2014)
Maria João Matos, Saleta Vazquez-Rodriguez, Eugenio Uriarte, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Future Medicinal Chemistry
|
June 17, 2021
Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion?
Maria João Matos
Molecules (Basel, Switzerland)
|
October 23, 2021
Coumarin and Its Derivatives-Editorial
Maria João Matos
Future Medicinal Chemistry
|
May 6, 2022
Treating neurodegenerative diseases with multitarget drugs: an interview with Maria João Matos
Maria João Matos
ACS Medicinal Chemistry Letters
|
June 16, 2022
Medicinal Chemistry in Portugal and Spain: A Strong Iberian Alliance
Maria João Matos, Maria-Jesus Blanco
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2023
Oxidation-labile linkers for controlled drug delivery
Aitor Carneiro, Lourdes Santana, Maria João Matos
Marine Drugs
|
January 20, 2023
Recent Advances in Biologically Active Coumarins from Marine Sources: Synthesis and Evaluation
Laura Fernández-Peña, Maria João Matos, Enol López
Molecules (Basel, Switzerland)
|
January 22, 2021
Trending Topics on Coumarin and Its Derivatives in 2020
Aitor Carneiro, Maria João Matos, Eugenio Uriarte, et al.
Future Medicinal Chemistry
|
February 21, 2023
Propargylamine: an important moiety in drug discovery
Aitor Carneiro, Eugenio Uriarte, Fernanda Borges, et al.
Expert Opinion on Drug Discovery
|
March 16, 2026
The futility of the familiar: rethinking strategies for the development of small molecules for neurodegenerative disorders
Manuel Novas, Maria João Matos, Christina Li Lin Chai
Expert Opinion on Therapeutic Patents
|
January 20, 2015
Potential pharmacological uses of chalcones: a patent review (from June 2011 - 2014)
Maria João Matos, Saleta Vazquez-Rodriguez, Eugenio Uriarte, et al.
Page
of 7